These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 25767890)
1. miR-185 plays an anti-hypertrophic role in the heart via multiple targets in the calcium-signaling pathways. Kim JO; Song DW; Kwon EJ; Hong SE; Song HK; Min CK; Kim DH PLoS One; 2015; 10(3):e0122509. PubMed ID: 25767890 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-30b-5p is involved in the regulation of cardiac hypertrophy by targeting CaMKIIδ. He J; Jiang S; Li FL; Zhao XJ; Chu EF; Sun MN; Chen MZ; Li H J Investig Med; 2013 Mar; 61(3):604-12. PubMed ID: 23360843 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-328 as a regulator of cardiac hypertrophy. Li C; Li X; Gao X; Zhang R; Zhang Y; Liang H; Xu C; Du W; Zhang Y; Liu X; Ma N; Xu Z; Wang L; Chen X; Lu Y; Ju J; Yang B; Shan H Int J Cardiol; 2014 May; 173(2):268-76. PubMed ID: 24631114 [TBL] [Abstract][Full Text] [Related]
4. NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression. Wang T; Zhai M; Xu S; Ponnusamy M; Huang Y; Liu CY; Wang M; Shan C; Shan PP; Gao XQ; Wang K; Chen XZ; Liu J; Xie JY; Zhang DY; Zhou LY; Wang K Theranostics; 2020; 10(2):553-566. PubMed ID: 31903137 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase. Wang YS; Zhou J; Hong K; Cheng XS; Li YG Cell Physiol Biochem; 2015; 35(4):1546-56. PubMed ID: 25792377 [TBL] [Abstract][Full Text] [Related]
6. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes. MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of miR-223 Tips the Balance of Pro- and Anti-hypertrophic Signaling Cascades toward Physiologic Cardiac Hypertrophy. Yang L; Li Y; Wang X; Mu X; Qin D; Huang W; Alshahrani S; Nieman M; Peng J; Essandoh K; Peng T; Wang Y; Lorenz J; Soleimani M; Zhao ZQ; Fan GC J Biol Chem; 2016 Jul; 291(30):15700-13. PubMed ID: 27226563 [TBL] [Abstract][Full Text] [Related]
8. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy. Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844 [TBL] [Abstract][Full Text] [Related]
9. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927 [TBL] [Abstract][Full Text] [Related]
10. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways. Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-350 induces pathological heart hypertrophy by repressing both p38 and JNK pathways. Ge Y; Pan S; Guan D; Yin H; Fan Y; Liu J; Zhang S; Zhang H; Feng L; Wang Y; Xu R; Yin JQ Biochim Biophys Acta; 2013 Jan; 1832(1):1-10. PubMed ID: 23000971 [TBL] [Abstract][Full Text] [Related]
12. Interaction between NFκB and NFAT coordinates cardiac hypertrophy and pathological remodeling. Liu Q; Chen Y; Auger-Messier M; Molkentin JD Circ Res; 2012 Apr; 110(8):1077-86. PubMed ID: 22403241 [TBL] [Abstract][Full Text] [Related]
13. miR-374 promotes myocardial hypertrophy by negatively regulating vascular endothelial growth factor receptor-1 signaling. Lee JS; Song DW; Park JH; Kim JO; Cho C; Kim DH BMB Rep; 2017 Apr; 50(4):208-213. PubMed ID: 27802840 [TBL] [Abstract][Full Text] [Related]
14. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy. Wang K; Long B; Zhou J; Li PF J Biol Chem; 2010 Apr; 285(16):11903-12. PubMed ID: 20177053 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA cardiac hypertrophy-associated regulator governs cardiac hypertrophy via regulating miR-20b and the downstream PTEN/AKT pathway. Zhang M; Jiang Y; Guo X; Zhang B; Wu J; Sun J; Liang H; Shan H; Zhang Y; Liu J; Wang Y; Wang L; Zhang R; Yang B; Xu C J Cell Mol Med; 2019 Nov; 23(11):7685-7698. PubMed ID: 31465630 [TBL] [Abstract][Full Text] [Related]
17. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy. Dong DL; Chen C; Huo R; Wang N; Li Z; Tu YJ; Hu JT; Chu X; Huang W; Yang BF Hypertension; 2010 Apr; 55(4):946-52. PubMed ID: 20177001 [TBL] [Abstract][Full Text] [Related]